Cargando…

Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective

Detalles Bibliográficos
Autores principales:	La Sala, Lucia, Luzi, Livio, Pontiroli, Antonio E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346795/ https://www.ncbi.nlm.nih.gov/pubmed/32807635 http://dx.doi.org/10.1016/j.numecd.2020.07.007

Ejemplares similares

SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
por: Verma, Henu Kumar, et al.
Publicado: (2021)

Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity – diabetes?
por: Pontiroli, Antonio E., et al.
Publicado: (2020)

Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection
por: Steels, Sophie, et al.
Publicado: (2022)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

Painless thyroiditis in SARS-CoV-2 infection()
por: Barahona San Millán, Rebeca, et al.
Publicado: (2021)

Chronic kidney disease is associated with worse outcomes following SARS-CoV2 infection among 18647 patients: A population-based cohort study
por: Fidalgo, Pedro, et al.
Publicado: (2022)

Chronic kidney disease is associated with worse outcomes following SARS-CoV2 infection among 18647 patients: A population-based cohort study
por: Fidalgo, Pedro, et al.
Publicado: (2022)

Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Baba, Atsunori, et al.
Publicado: (2023)

COVID-19 (SARS-COV-2): Transformations in medicine, our existence, and world order?
por: Bhattacharya, Jayanta
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic()
por: Ibáñez-Vizoso, Jesús E., et al.
Publicado: (2020)

A global health perspective on SARS-CoV-2—hazards, disaster and hope
por: Meyer, Sascha, et al.
Publicado: (2020)

International Mental Health perspectives on the novel coronavirus SARS-CoV-2 pandemic
por: Ibáñez-Vizoso, Jesús E., et al.
Publicado: (2020)

Might hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?
por: Caruso, Arturo A., et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations
por: Finsterer, Josef, et al.
Publicado: (2022)

Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
por: Jefferson, Tom, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on pre-existing mental health problems
por: Chatterjee, Seshadri Sekhar, et al.
Publicado: (2020)

SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)

Reply to “Indications and timing for tracheostomy in patients with SARS CoV2‐related” by Ferri et al.
por: Mattioli, Francesco, et al.
Publicado: (2020)

Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone()
por: Feria, Lucia, et al.
Publicado: (2022)

Reply to “Intensification of an Essential Tremor by SARS-CoV-2”
por: Passaretti, Massimiliano, et al.
Publicado: (2022)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer
por: La Vignera, Sandro, et al.
Publicado: (2020)

Cranial multineuritis associated with anti-GM2 ganglioside antibodies after SARS-CoV-2 infection
por: Torres Gómez, Antonio, et al.
Publicado: (2023)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Prevention of Diabetes and Cardiovascular Disease in Obesity
por: La Sala, Lucia, et al.
Publicado: (2020)

New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
por: La Sala, Lucia, et al.
Publicado: (2021)

Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Sala, Lucia La, et al.
Publicado: (2021)

Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643
por: La Sala, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19la89vf625dack35eu6hkls9a